Research Collaboration Has Studied Aging Immune Cells
Researchers have launched a new project to identify how age-related protein changes impact how your body responds to vaccines.
Updated on Oct. 10, 2026 in Senior Health
Live Poll
Do you support prioritizing research aimed at increasing vaccine effectiveness for the older population?
The Malaghan Institute and the University of Dundee have begun a collaborative research project investigating why immune cells in older people experience a decline in protein regulation. This study, which includes partnership with the Rauawaawa Kaumātua Charitable Trust, aims to link protein levels in immune cells to functional vaccine responses.
Why it matters
Understanding how immune cell protein regulation fails with age is critical because vaccines often show decreased effectiveness in older populations. Identifying these biological mechanisms could lead to more effective immunization strategies that reduce hospitalizations and promote healthy longevity.
This research project utilizes unbiased protein surveying technology to analyze rare immune cells collected from older individuals following vaccination. Researchers are currently evaluating these protein levels against functional changes in immune response, though the study remains in the preliminary phase.
The players
Malaghan Institute
A New Zealand-based independent medical research institute focused on immunological breakthroughs and vaccine development.
University of Dundee
A Scottish research university that provides advanced analytical technology for cellular protein surveys.
Rauawaawa Kaumātua Charitable Trust
A Hamilton-based organization that supports older adults and is participating in the research engagement process.
The details
Researchers are using specialized technology from the University of Dundee to conduct an unbiased survey of proteins in small samples of immune cells. By isolating these rare cells from blood samples collected after vaccination, the team is mapping how protein regulation changes in older adults. The goal is to determine how these specific intracellular modifications interfere with the immune system's ability to mount a robust protective response to common vaccines.
Timeline
The research collaboration was reported on October 10, 2026.
Health Landscape
This project contributes to the broader field of immunosenescence, which studies how the immune system declines over a lifetime. It specifically addresses the limitation of current immunization standards, which often overlook the unique protein-regulation challenges present in older populations.
This development highlights the ongoing scientific effort to improve vaccine protection for older adults. You can discuss any concerns regarding vaccine effectiveness or immune health with your doctor during your next wellness visit.
The takeaway
While this study focuses on the cellular drivers of immune decline, it highlights the importance of staying current with age-appropriate immunization schedules. You can track your personal health metrics by documenting the dates of your vaccinations and discussing any side effects or concerns with your physician.
Further reading
For more information on how the immune system evolves with age, see our section on Senior Health.
Source note: This article includes information reported by RNZ.
Live Poll
Do you support prioritizing research aimed at increasing vaccine effectiveness for the older population?
